Congress of Clinical Rheumatology Annual Meeting
Correct therapy sequence ‘essential’ for patients with osteoporosis
SAN DIEGO — Matching the correct therapy sequence to the right patient is critical when caring for patients with osteoporosis, according to a speaker at the Congress of Clinical Rheumatology West.
Rheumatologists managing pain should advise patients on opioid regulations
SAN DIEGO — Rheumatologists must advise patients who receive opioids about the various regulations governing their use, according to a speaker at the Congress of Clinical Rheumatology West.
‘Stigma’ surrounding opioids, pain management harms patients, feeds biases
SAN DIEGO — The stigma surrounding opioid use and pain management continues to significantly impact patient care in rheumatology today, according to a presentation at the Congress of Clinical Rheumatology West.
Older patients demonstrate inflammation, immune activity similar to rheumatic diseases
SAN DIEGO — Older individuals experience reduced immune activity and increased inflammation that often resemble rheumatic and autoimmune diseases, according to data presented at the Congress of Clinical Rheumatology West.
T-scores alone insufficient in assessing osteoporosis in patients with osteopenia
SAN DIEGO — Patients with low bone density may have osteoporosis despite registering a bone mineral density score higher than –2.5, according to a speaker at the Congress of Clinical Rheumatology West
Collaboration with pulmonology key to managing ILD in autoimmune disease
SAN DIEGO — A clear intervention plan and collaboration with pulmonology are key to managing patients with interstitial lung disease in autoimmune conditions, according to a speaker at the Congress of Clinical Rheumatology West.
Polymyositis diagnoses ‘exceedingly rare’ in shift toward inclusion body myositis
SAN DIEGO — Many patients who might have previously been diagnosed with polymyositis are now being treated for inclusion body myositis, according to a speaker at the Congress of Clinical Rheumatology West.
Patients with scleroderma should receive regular pulmonary arterial hypertension screening
SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective tissue diseases should make regular screening a priority, according to a speaker at the Congress of Clinical Rheumatology West.
‘Muddled field’ of hypermobility leaves patients with unaddressed, misunderstood pain
SAN DIEGO — The broad spectrum of hypermobility and connective tissue disorders has proven difficult to define and categorize, leaving many patients in pain, according to a speaker at the Congress of Clinical Rheumatology West.
‘Aggressive therapy’ key in axial spondyloarthritis despite lack of T2T recommendation
SAN DIEGO — Although current American College of Rheumatology guidelines eschew treat-to-target for axial spondyloarthritis, “aggressive treatment” is still needed to manage the disease, noted a speaker here.